In the BioHarmony Drug Report Database

"Preview" Icon

Elbasvir

Zepatier (elbasvir) is a small molecule pharmaceutical. Elbasvir was first approved as Zepatier on 2016-01-28. It is used to treat chronic hepatitis c and hepatitis c in the USA. It has been approved in Europe to treat chronic hepatitis c. Zepatier’s patent is valid until 2031-05-04 (FDA).

 

Trade Name

 

Zepatier
 

Common Name

 

elbasvir
 

ChEMBL ID

 

CHEMBL3039514
 

Indication

 

chronic hepatitis c, hepatitis c
 

Drug Class

 

Antivirals: NS5A inhibitors

Image (chem structure or protein)

Elbasvir structure rendering